Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Su

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|July 14, 2022
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|August 5, 2021
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021Anne M Hause, Julianne Gee, James Baggs, et al.
Vaccine|April 16, 2026
Safety of seasonal inactivated influenza vaccines in children 6 months-17 years of age in the Vaccine Adverse Events Reporting System (VAERS) 2018-2023: before, during, and after the COVID-19 pandemic public health emergencyE Gloria Anyalechi, Paige L Marquez, Mary N Rubin, et al.
Vaccine|May 29, 2023
COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety officeElaine R Miller, Pedro L Moro, Tom T Shimabukuro, et al.
MMWR. Morbidity and Mortality Weekly Report|July 28, 2022
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
JAMA Network Open|February 1, 2023
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United StatesWinston E Abara, Julianne Gee, Paige Marquez, et al.
The Lancet. Infectious Diseases|March 10, 2022
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safeHannah G Rosenblum, Julianne Gee, Ruiling Liu, et al.
American Journal of Otolaryngology|August 3, 2024
Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalinkW Katherine Yih, Jonathan Duffy, John R Su, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|July 14, 2022
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|August 5, 2021
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021Anne M Hause, Julianne Gee, James Baggs, et al.
Vaccine|April 16, 2026
Safety of seasonal inactivated influenza vaccines in children 6 months-17 years of age in the Vaccine Adverse Events Reporting System (VAERS) 2018-2023: before, during, and after the COVID-19 pandemic public health emergencyE Gloria Anyalechi, Paige L Marquez, Mary N Rubin, et al.
Vaccine|May 29, 2023
COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety officeElaine R Miller, Pedro L Moro, Tom T Shimabukuro, et al.
MMWR. Morbidity and Mortality Weekly Report|July 28, 2022
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
JAMA Network Open|February 1, 2023
Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United StatesWinston E Abara, Julianne Gee, Paige Marquez, et al.
The Lancet. Infectious Diseases|March 10, 2022
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safeHannah G Rosenblum, Julianne Gee, Ruiling Liu, et al.
American Journal of Otolaryngology|August 3, 2024
Tinnitus after COVID-19 vaccination: Findings from the vaccine adverse event reporting system and the vaccine safety datalinkW Katherine Yih, Jonathan Duffy, John R Su, et al.
Pageof 6